DS
PASG icon

David Shaw’s Passage Bio PASG Stock Holding History

David Shaw’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-501
Closed -$6.6K – 4527
2023
Q3 		$6.6K Sell
501
-6,214
-93% -$102K ﹤0.01% 4110
2023
Q2 		$126K Sell
6,715
-7,002
-51% -$139K ﹤0.01% 3807
2023
Q1 		$263K Sell
13,717
-4,421
-24% -$120K ﹤0.01% 3800
2022
Q4 		$501K Sell
18,138
-819
-4% -$20.7K ﹤0.01% 3851
2022
Q3 		$474K Buy
18,957
+839
+5% +$33.1K ﹤0.01% 4067
2022
Q2 		$855K Buy
18,118
+3,081
+20% +$144K ﹤0.01% 3738
2022
Q1 		$932K Buy
15,037
+8,242
+121% +$679K ﹤0.01% 3973
2021
Q4 		$863K Buy
+6,795
New +$1.11M ﹤0.01% 4049

Other funds holding PASG

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

David Shaw's PASG Position: Q4 2023 in Review

David Shaw sold out of Passage Bio (PASG) in Q4 2023, closing a stake of 501 shares — an estimated $6.6K sold.

David Shaw first reported a position in PASG in Q4 2021 and held it in 8 quarters. The position peaked at $932K in Q1 2022. 50 funds tracked by Wall St. Rank hold PASG as of Q4 2023.

  • David Shaw reported no remaining Passage Bio position as of Q4 2023 after selling out during the quarter.
  • David Shaw sold 501 Passage Bio shares in Q4 2023, an estimated $6.6K.
  • David Shaw first reported a position in Passage Bio in Q4 2021 and held it in 8 quarters.
  • David Shaw's Passage Bio position peaked at $932K in Q1 2022.
  • 50 funds tracked by Wall St. Rank held Passage Bio as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.